Business Wire

Andersen Global Enters Malawi

Share

Andersen Global establishes a foothold in the Malawi market through a Collaboration Agreement with Knight & Knight, bolstering its platform on the African continent and adding additional coverage in the eastern region.

Established in 2003, Knight & Knight is a full-service law firm specializing in all facets of business law with capabilities in banking and finance, litigation, intellectual property, commercial, real estate, employment, mergers and acquisitions, and regulatory matters. With two partners and six professionals, the firm serves individuals and organizations of various sizes, representing a large number of businesses across the country as well as transactional entities, multinational corporations, banking and financial institutions, public sector undertakings, various ministries, state and central government authorities, and nongovernmental organizations.

“At the core of our business, our philosophy has always been to offer best-in-class services designed to meet our clients’ specific needs,” Office Managing Partner Yambani Mulemba said. “Our collaboration with Andersen Global strengthens our commitment to offering our clients effective, comprehensive solutions and further enhances our growth and capabilities in the African market and globally.”

“Knight & Knight has expanded and diversified their areas of practice in the past years, and they have successfully positioned themselves as a predominant firm in the market,” Andersen Global Chairman and Andersen CEO Mark Vorsatz said. “Collaborating with Yambani and the team will enable us to work even more effectively across the region with their expertise and our strongly aligned values of stewardship and transparency. This is another key peg to our expansion strategy in Africa.”

Andersen Global is an international association of legally separate, independent member firms comprised of tax and legal professionals around the world. Established in 2013 by U.S. member firm Andersen Tax LLC, Andersen Global now has more than 7,000 professionals worldwide and a presence in over 231 locations through its member firms and collaborating firms.

Contact information

Megan Tsuei
Andersen Global
415-764-2700

About Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

VicTrack transforms rail and government infrastructure with ADVA FSP 30004.3.2021 09:00:00 CETPress release

ADVA (FSE: ADV) today announced that VicTrack is building its new Transport and Government Secure Network (TGSN) on the ADVA FSP 3000. The infrastructure enables railway operators to harness next-generation signaling technologies and provides high-speed connectivity for government agencies. Carrying services at speeds up to 100Gbit/s throughout the Australian state of Victoria, the flexible and fully redundant ROADM network also empowers VicTrack to offer highly reliable and cost-efficient wholesale services at 10Gbit/s and 100Gbit/s. What’s more, the FSP 3000 creates a modular network architecture, which is scalable and ready to support future transport innovation. ADVA’s team is also providing a comprehensive range of professional services from network design to ongoing training and support. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210304005026/en/ ADVA’s open networking technology is helping VicTrack deliver mission

IDEMIA to Participate in the UK Government’s Digital Identity Pilot4.3.2021 09:00:00 CETPress release

Pursuant to UK government standards, DCS will provide a powerful new way to help verify UK passport holders’ identity, underpinned by security and user experience. It will help prevent fraud, speed up checks and allow people to prove their identity for both face-to-face and online transactions. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210304005360/en/ (Photo: Business Wire) The DCS was previously only available for use in government transactions, however can now be used by pilot-participating private sector firms to check passport information provided by UK citizens against government held data. With citizen consent, service providers will use IDEMIA’s IDway solution to instantly check people’s passport details match the UK government’s passport office database. The DCS will then respond yes or no to confirm whether or not the passport details are valid. People’s private data are protected at all times. Matt Warman,UK

Flagship Report From Arthur D. Little Urges Telcos to Accelerate Growth by Embracing New Services and Reconfiguring Network Assets4.3.2021 09:00:00 CETPress release

Arthur D. Little (ADL) today released a major telecoms report that identifies key strategies to unlock the value of network assets, diversify product offerings, and succeed in a 5G world. Entitled “Time to accelerate growth” and based on a global survey of over 100 C-level executives, it looks at the ways in which telcos can meet the challenge of soaring data-traffic demands while moving beyond traditional connectivity and legacy services. The report identifies three main areas that telcos should concentrate on going forward: Maximizing 5G’s potential. To further enhance customer experience for B2C, telcos and media companies need to form alliances and use 5G as a means to create new and compelling products for consumers – for example, premium bundles that combine content, experience and devices in novel and exciting ways. To provide solutions to B2B customers beyond connectivity, mobile private networks (MPNs) and network slicing offer key opportunities for 5G monetization. To capture

Galderma Continues Global Growth Ambition With Sculptra ® (injectable poly-L-lactic Acid) Re-launch in Europe4.3.2021 08:57:00 CETPress release

Galderma today announced a European re-launch of Sculptra® (injectable poly-L-lactic acid) - a collagen stimulator - with an updated administration protocol. This means that the product is ready for use more quickly following reconstitution, with increased levels of comfort for patients. Sculptra® can now be used immediately following a two-minute reconstitution and with the optional addition of lidocaine for patient comfort. Previously, healthcare professionals had to wait two hours following reconstitution to administer the product. Sculptra® now has the fastest reconstitution protocol of any injectable poly-L-lactic acid (PLLA) available in Europe, representing a significant growth opportunity for Galderma. “Sculptra® has been my go-to tool for treating skin laxity resulting from aging and collagen loss in my patients’ skin, helping restore a youthful appearance,” said Dr. Christoph Martschin, Dermatologist, Akademikliniken, Department of Dermatology, Stockholm, and a featured speak

Exscientia Completes $100 million Series C Financing Round With BlackRock Funds4.3.2021 08:00:00 CETPress release

Exscientia, a clinical stage pharmatech pioneering the use of artificial intelligence (AI) to design new drugs, today announced that funds managed by BlackRock joined the Company’s Series C investment round. Including existing Series C investors, Novo Holdings, Evotec, Bristol Myers Squibb, and GT Healthcare Capital, the round totalled $100 million in funding. This new capital will be used to support Exscientia’s platform development towards autonomous drug design. In addition, the company will extend its proprietary pipeline into clinical trials and expand existing capabilities in biological analytics that support target selection and portfolio development. With the company’s end-to-end AI-first drug discovery platform, CentaurAI™, Exscientia has been able to generate novel drugs and overcome conventional drug discovery limitations several years faster than industry benchmarks. Exscientia has demonstrated the platform’s capabilities by creating the first fully AI-designed drug to ente

OpenGate Capital Portfolio Company, SMAC, Completes Sale of AXTER4.3.2021 08:00:00 CETPress release

OpenGate Capital, a global private equity firm, announced today that its portfolio company, SMAC, has completed the sale of its subsidiary, AXTER, which is focused on the production of waterproofing membranes, to IKO, a leader in global roofing and related products based in Canada. Terms of the agreement were not disclosed. SMAC, a global manufacturer of waterproofing and building envelope solutions headquartered in France, is representative of OpenGate’s strong record of acquiring complex, industrial, and specifically building and construction related businesses across North America and Europe. Andrew Nikou, OpenGate’s Founder and CEO, stated, “With the successful completion of this transaction, SMAC will be able to sharpen its focus on its core operations and customer solutions. Our team at OpenGate will continue to support management of SMAC as they further execute on its business strategy and unlock future growth opportunities.” The sale of AXTER, initially announced on October 5,

Liva Healthcare Attracts Top Medical Scientific Leaders to Global Advisory Board4.3.2021 08:00:00 CETPress release

A leading provider of scalable digital health coaching in Europe, Liva Healthcare (“Liva”), launches new Scientific Advisory Board. Liva has attracted some of Europe’s most respected scientific leaders within chronic conditions and behaviour change psychology to join its global Advisory Board. The board will oversee the medical quality of the programmes and conduct the latest scientific research into Liva’s behavioural change model. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210303005646/en/ Liva Healthcare (Photo: Business Wire) Liva is a health tech company that improve the lives of people at risk of, or living with, chronic conditions such as type 2 diabetes, obesity, and cardiovascular diseases by driving positive behavioural change. Liva recently announced a new funding round of EUR 24.5 million with the aim to expand its European operations. The Liva programmes are used by leading players in public healthcare, insu